Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stroke 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Obesity, Abdominal 1Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Laryngeal Neoplasms 1Kidney Failure, Chronic 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Diabetes Mellitus 1Delirium 1Coronary Artery Disease 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1COVID-19 1Advanced Breast Adenocarcinoma 1

Interventions

suvorexant 1Standard of Care 1Practice Guidelines as Topic 1Midazolam 1Interviews as Topic 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Delirium × Practice Guidelines as Topic × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡